126
Wales | Full Member
Institute of
Life Science
L ocati on
Swansea University
Singleton Park
Swansea
SA2 8PP
C ontact detai l s
Nia Morse
Project Manager
Enterprise & Innovation Team
T: 01792 513718
E: [email protected]
www.ils.swansea.ac.uk
@ILS_EI
UKSPA Directory 2017
The Institute of Life Science (ILS) is Wales’ premier purpose-built medical research
and business incubation facility. It is a partnership between Swansea University,
Welsh Government, the NHS, ABMU Health Board, and business partners. It provides
a cornerstone for the regional MediPark vision being developed as part of the ARCH
(A Regional Collaboration for Health) delivered in partnership between University Health
Boards, industry, academia, and Welsh Government. The vision for the ILS is to advance
medical science through multi- and inter-disciplinary research and innovation for the
benefit of human health, and to link those benefits to the economy by encouraging
interaction with other organisations in a spirit of Open Innovation.
Shaping the Future for the
He alth and We alth of Wales
The first phase of the ILS vision – valued
at £52m – delivered a state-of-the-art
building (ILS1) housing over 200
professional specialists in medical
research, high-performance computing,
business incubation, and technology
transfer. The second phase of the vision
– which received £28.8m funding – boasts
a further 6,000m 2 of facilities that build
capacity, expertise, and infrastructure to
benefit the nation’s health and wealth.
Standing adjacent to Singleton
Hospital, the award-winning ILS1 & ILS2
buildings house the College of Medicine’s
healthcare research, a range of fully-
operational business incubation units,
and the Joint Clinical Research Facility
(JCRF), fully equipped with a bedded
clinical trials unit and an imaging suite
with cutting-edge CT and MRI scanners.
ILS2 also houses the innovative Centre
for NanoHealth.
Other unique facilities at the ILS
include the EPSRC UK National Mass
Spectrometry Facility, the Haemostasis
Biomedical Research Unit, the Health
Informatics Research Laboratories, the
NHS Wales Research Informatics
Laboratories, and extensive high
performance computing capabilities
through HPC Wales.
The business centre is home to a
growing band of companies, including:
Haemair Ltd: Provides support for people
with lung disease or injury. Its technology
takes part of the blood circulation and
passes it through an “artificial lung” to
oxygenate the blood and remove carbon
dioxide. The aim is to provide patients
with mobility, allowing them to eat, drink
and talk instead of being immobile in
intensive care.
Haemaflow Ltd: Initially established to
exploit developments spun- off from
Haemair Ltd, its current priority is the
development of a device to improve the
safety and efficacy of transfusion blood.
Supported by a grant from Innovate UK.